Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Crinetics Pharmaceuticals (CRNX) Return on Assets (2018 - 2025)

Crinetics Pharmaceuticals has reported Return on Assets over the past 8 years, most recently at 0.4% for Q4 2025.

  • Quarterly results put Return on Assets at 0.4% for Q4 2025, down 15.0% from a year ago — trailing twelve months through Dec 2025 was 0.4% (down 15.0% YoY), and the annual figure for FY2025 was 0.36%, down 8.0%.
  • Return on Assets for Q4 2025 was 0.4% at Crinetics Pharmaceuticals, down from 0.34% in the prior quarter.
  • Over the last five years, Return on Assets for CRNX hit a ceiling of 0.23% in Q1 2025 and a floor of 0.61% in Q2 2023.
  • Median Return on Assets over the past 5 years was 0.36% (2022), compared with a mean of 0.38%.
  • Biggest five-year swings in Return on Assets: fell -25bps in 2023 and later surged 34bps in 2024.
  • Crinetics Pharmaceuticals' Return on Assets stood at 0.38% in 2021, then fell by -16bps to 0.44% in 2022, then increased by 26bps to 0.33% in 2023, then grew by 23bps to 0.25% in 2024, then tumbled by -60bps to 0.4% in 2025.
  • The last three reported values for Return on Assets were 0.4% (Q4 2025), 0.34% (Q3 2025), and 0.28% (Q2 2025) per Business Quant data.